These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 28755832)

  • 21. Tramadol dependence: a survey of spontaneously reported cases in Sweden.
    Tjäderborn M; Jönsson AK; Ahlner J; Hägg S
    Pharmacoepidemiol Drug Saf; 2009 Dec; 18(12):1192-8. PubMed ID: 19827010
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Not Available].
    Abadie D; Durrieu G; Roussin A; Montastruc JL;
    Therapie; 2013; 68(2):77-84. PubMed ID: 27392672
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Unexpected drug-induced Raynaud phenomenon: Analysis from the French national pharmacovigilance database.
    Bouquet É; Urbanski G; Lavigne C; Lainé-Cessac P
    Therapie; 2017 Oct; 72(5):547-554. PubMed ID: 28336160
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effectiveness of oral tramadol hydrochloride for chronic non-malignant pain].
    Kitahara M; Kojima K; Hanada M; Kuriyama Y; Ohmura A
    Masui; 2009 Aug; 58(8):971-5. PubMed ID: 19702210
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of pain with sustained-release tramadol 100, 150, 200 mg: results of a post-marketing surveillance study.
    Nossol S; Schwarzbold M; Stadler T
    Int J Clin Pract; 1998 Mar; 52(2):115-21. PubMed ID: 9624795
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Seizure after overdose of tramadol.
    Tobias JD
    South Med J; 1997 Aug; 90(8):826-7. PubMed ID: 9258310
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Can tramadol really induce hyponatraemia? A pharmacovigilance study.
    de Canecaude C; Rousseau V; Chebane L; Lafaurie M; Durrieu G; Montastruc JL
    Br J Clin Pharmacol; 2021 Feb; 87(2):683-686. PubMed ID: 32470196
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tramadol-related hypoglycaemia and tramadol-induced anorexia.
    Jolobe O
    Br J Hosp Med (Lond); 2015 Apr; 76(4):249. PubMed ID: 25853362
    [No Abstract]   [Full Text] [Related]  

  • 29. Health benefits of an adverse events reporting system for chronic pain patients using long-term opioids.
    Planelles B; Margarit C; Ajo R; Sastre Y; Muriel J; Inda MD; Esteban MD; Peiró AM
    Acta Anaesthesiol Scand; 2019 Feb; 63(2):248-258. PubMed ID: 30109708
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drug-induced adverse reactions via breastfeeding: a descriptive study in the French Pharmacovigilance Database.
    Soussan C; Gouraud A; Portolan G; Jean-Pastor MJ; Pecriaux C; Montastruc JL; Damase-Michel C; Lacroix I
    Eur J Clin Pharmacol; 2014 Nov; 70(11):1361-6. PubMed ID: 25183382
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of Medicine Withdrawal on Reporting of Adverse Events Involving Therapeutic Alternatives: A Study from the French Spontaneous Reporting Database.
    Pageot C; Bezin J; Smith A; Arnaud M; Salvo F; Haramburu F; Bégaud B; Pariente A;
    Drug Saf; 2017 Nov; 40(11):1099-1107. PubMed ID: 28664354
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Retrospective analysis reveals significant association of hypoglycemia with tramadol and methadone in contrast to other opioids.
    Makunts T; U A; Atayee RS; Abagyan R
    Sci Rep; 2019 Aug; 9(1):12490. PubMed ID: 31462666
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Disproportionality Analysis of Safety Signals for a Wide Variety of Opioid-Related Adverse Events in Elderly Patients Using the Japanese Adverse Drug Event Report (JADER) Database.
    Omoto T; Asaka J; Sakai T; Sato F; Goto N; Kudo K
    Biol Pharm Bull; 2021; 44(5):627-634. PubMed ID: 33952819
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Factors associated with serious adverse reactions to cholinesterase inhibitors: a study of spontaneous reporting.
    Pariente A; Sanctussy DJ; Miremont-Salamé G; Moore N; Haramburu F; Fourrier-Réglat A;
    CNS Drugs; 2010 Jan; 24(1):55-63. PubMed ID: 20030419
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of Online Patient Reviews and National Pharmacovigilance Data for Tramadol-Related Adverse Events: Comparative Observational Study.
    Park S; Choi SH; Song YK; Kwon JW
    JMIR Public Health Surveill; 2022 Jan; 8(1):e33311. PubMed ID: 34982723
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Comparative relevance of declaration of side effects by patients and health professionals].
    Lagneau A; Vigier C; Marianna A; Serfaty R; Rocher F; Spreux A; Drici MD
    Therapie; 2017 Dec; 72(6):625-633. PubMed ID: 28780021
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Pristinamycin/Vitamin k antagonists drug interaction: a French pharmacovigilance database study].
    Guiboux AL; Dautriche A; Rocher F; Bruel M; Sgro C;
    Therapie; 2014; 69(5):391-4. PubMed ID: 25047671
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Review of the Food and Drug Administration Adverse Event Reporting System for Tramadol-Related Hypoglycemia.
    Juba KM; van Manen RP; Fellows SE
    Ann Pharmacother; 2020 Mar; 54(3):247-253. PubMed ID: 31648533
    [No Abstract]   [Full Text] [Related]  

  • 39. Abuse, dependence, or withdrawal associated with tramadol.
    Brinker A; Bonnel RA; Beitz J
    Am J Psychiatry; 2002 May; 159(5):881; author reply 881-2. PubMed ID: 11986164
    [No Abstract]   [Full Text] [Related]  

  • 40. Systemic adverse drug reactions: a preliminary report from the regional pharmacovigilance center, western Nepal.
    P S; P M; Pr S
    Pak J Pharm Sci; 2008 Oct; 21(4):465-7. PubMed ID: 18930872
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.